Global Animal Antibiotics and Antimicrobials Market to grow with 4.24% CAGR through 2022

December 03, 2019


According to the research report titled ‘Global Animal Antibiotics and Antimicrobials Market Analysis - Product Type, Delivery Type, Type of Animals, Company Analysis, Regional and Country Analysis (2017-2022) - By Product Type (Penicillins, Fluoroguinolones, Aminoglycosides, Tetracyclines, Fluoroguinolones, Macrolides, Sulfonamides, Lincosamides, Cephalosporins, Others), By Delivery Type (Premixes, Oral Powder, Oral Solution, Injections and Others), By Type of Animals (Farm Animals, Companion Animals)’ available with Market Study Report LLC, the global animal antibiotics and antimicrobials market is estimated to grow with a CAGR of 4.24% during the period of 2017-2022.
 

Rising demand for protein-rich animal products and surging trend of pet ownership among consumers are major factors driving the growth of animal antibiotics and antimicrobials market for the forecast period. Growing population and rising disposable income of the middle-class segment are aiding the market outlook. Increasing concerns over animal health, combined with improved awareness regarding benefits of animal-derived products, and rising healthcare expenditure are augmenting the demand for animal antibiotics and antimicrobials across the world.
 

Based on type, animal antibiotics and antimicrobials market is categorized into cephalosporins, lincosamides, sulfonamides, macrolides, fluoroguinolones, tetracyclines, aminoglycosides, penicillins, and others. According to the report, tetracycline segment is projected to continue its dominance in animal antimicrobials and antibiotics market for the analysis period.
 

As per delivery type, animal antibiotics and antimicrobials industry is classified into oral powder, premixes, injections, oral solutions, and others. Whereas in terms of type of animals, the market is segmented into companion animals and farm animals.
 

Considering the geographical landscape, the global animal antibiotics and antimicrobials market is divided into regions namely, Europe, North America, Asia-Pacific, and rest of the world, with key focus on countries such as Canada, US, UK, France, Germany, India, China, and Japan.
 

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/1378480/
 

The report cites that APAC animal antibiotics and antimicrobials market will register decent growth over the forecast timeline, owing to surging trend of pet humanization, growing animal population, and escalating per capita income of the middle-class segment.
 

The key players in the global animal antibiotics and antimicrobials market are Dechra Pharmaceuticals Plc, Merck & Co., Inc., Bayer AG, Boehringer Ingelheim GmbH, Phibro Animal Health Corp., Eli Lilly & Co., Ceva Sante Animale, Vetoquinol SA, Virbac, and Zoetis, Inc. 


Frequently Asked Questions (FAQ) :

Rising demand for protein-rich animal products and surging trend of pet ownership among consumers are major factors driving the growth of the animal antibiotics and antimicrobials market for the forecast period. Growing population and rising disposable income of the middle class segment are aiding the market growth. Increasing concerns over animal health, combined with improved awareness regarding benefits of animal-derived products, and rising healthcare expenditure are augmenting the demand for animal antibiotics and antimicrobials across the world.
Based on type, the global animal antibiotics and antimicrobials market is categorized into cephalosporins, lincosamides, sulfonamides, macrolides, fluoroguinolones, tetracyclines, aminoglycosides, penecillins and others. According to the report, tetracycline segment is projected to continue its dominance in animal antimicrobials and antibiotics market for the analysis period. As per delivery type, the industry is classified into oral powder, premixes, injections, oral solutions, and others, whereas in terms of type of animals, the market is segmented into companion animals and farm animals.
APAC animal antibiotics and antimicrobials market will register decent growth over the forecast timeline, owing to surging trend of pet humanization, growing animal population, and escalating per capita income of the middle-class segment.
The key players in the global animal antibiotics and antimicrobials market are Dechra Pharmaceuticals Plc, Merck & Co., Inc., Bayer AG, Boehringer Ingelheim GmbH, Phibro Animal Health Corp., Eli Lilly & Co., Ceva Sante Animale, Vetoquinol SA, Virbac and Zoetis Inc.